Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.395
AS - Asia 4.965
EU - Europa 2.907
SA - Sud America 919
OC - Oceania 252
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.264
CN - Cina 1.803
SG - Singapore 1.409
IT - Italia 978
HK - Hong Kong 896
BR - Brasile 784
GB - Regno Unito 516
SE - Svezia 361
DE - Germania 259
AU - Australia 246
RU - Federazione Russa 237
VN - Vietnam 236
KR - Corea 178
FI - Finlandia 118
ID - Indonesia 114
FR - Francia 87
CA - Canada 67
AR - Argentina 58
BG - Bulgaria 58
IN - India 56
NL - Olanda 49
MX - Messico 44
AT - Austria 39
TR - Turchia 37
BD - Bangladesh 36
LT - Lituania 30
PL - Polonia 30
ZA - Sudafrica 30
IQ - Iraq 28
JP - Giappone 28
ES - Italia 27
EC - Ecuador 23
IE - Irlanda 18
PK - Pakistan 18
UA - Ucraina 16
CO - Colombia 15
UZ - Uzbekistan 15
MY - Malesia 14
KE - Kenya 13
MA - Marocco 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
EG - Egitto 11
AZ - Azerbaigian 10
CH - Svizzera 10
CZ - Repubblica Ceca 9
RS - Serbia 9
BE - Belgio 8
PE - Perù 8
RO - Romania 8
SA - Arabia Saudita 8
TH - Thailandia 8
JO - Giordania 7
PY - Paraguay 7
TW - Taiwan 7
HU - Ungheria 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
AL - Albania 5
CU - Cuba 5
GE - Georgia 5
LU - Lussemburgo 5
NP - Nepal 5
BY - Bielorussia 4
CL - Cile 4
EE - Estonia 4
IL - Israele 4
IR - Iran 4
OM - Oman 4
PA - Panama 4
UY - Uruguay 4
BO - Bolivia 3
DZ - Algeria 3
KG - Kirghizistan 3
NG - Nigeria 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GD - Grenada 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 15.511
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.414
Singapore 927
Hong Kong 896
Hefei 890
Ashburn 666
Chandler 427
Fairfield 395
London 311
Nyköping 283
Beijing 227
New York 181
Seoul 178
Woodbridge 169
Perth 167
Houston 165
Seattle 157
Wilmington 140
Cambridge 126
The Dalles 125
Los Angeles 124
Chicago 109
San Diego 106
Jakarta 97
Munich 97
Bologna 96
Milan 87
Ho Chi Minh City 84
São Paulo 79
Buffalo 76
Shanghai 74
Dallas 73
Modena 71
Princeton 69
Ann Arbor 67
Helsinki 67
Rome 67
Southend 63
Moscow 60
Sofia 56
Kent 50
Hanoi 48
Salt Lake City 39
Sydney 38
Lappeenranta 29
Nuremberg 29
Toronto 28
Redondo Beach 27
Kilburn 26
Columbus 24
Parma 23
Guangzhou 22
Johannesburg 22
Rio de Janeiro 22
Turku 22
Frankfurt am Main 20
Reggio Emilia 20
Amsterdam 19
Mexico City 19
Tokyo 19
Council Bluffs 18
Naples 18
Vienna 18
Atlanta 17
Dublin 17
Elk Grove Village 17
Orem 17
Phoenix 17
Portsmouth 17
Stockholm 17
Turin 17
Denver 16
Montreal 16
Warsaw 16
Belo Horizonte 15
Campinas 15
Düsseldorf 15
Jacksonville 15
Eugene 14
Tampa 14
Tashkent 14
Boston 13
Brasília 13
Haiphong 13
Ankara 12
Biên Hòa 12
Brooklyn 12
Curitiba 12
Perugia 12
Baghdad 11
Chennai 11
Florence 11
Fortaleza 11
Lauterbourg 11
Melbourne 11
Miami 11
Norwalk 11
Paris 11
Poplar 11
Ribeirão Preto 11
Salvador 11
Totale 10.583
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 437
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 267
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 255
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 236
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 216
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 195
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 195
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 194
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 174
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 169
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 168
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 165
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 165
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 163
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 160
What do we do about atrial high rate episodes? 160
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 159
Female sex and stroke in atrial fibrillation: an intriguing relationship 158
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 155
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 153
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 152
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 147
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 143
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 143
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 139
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 137
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 137
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 137
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 136
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 135
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications 135
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 135
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 133
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 133
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 133
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 132
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 131
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 131
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 129
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 128
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 128
Atrial fibrillation in pneumonia: what clinical implications at long-term? 127
Anthropometric parameters and radiation doses during percutaneous coronary procedures 126
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 126
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 125
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 124
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 124
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 124
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 123
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 123
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 122
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 122
Atrial fibrillation burden: Stepping beyond the categorical characterization 121
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 121
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 121
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 121
Single-lead VDD pacing: a literature review on short-term and long-term performance 120
Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case–Control Study 118
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 117
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 115
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 115
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 114
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 113
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 112
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 112
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 111
Clinical decisions for appropriate management of patients with atrial fibrillation 111
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 111
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 110
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 110
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 109
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation 108
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 108
GESTIONE CLINICA, COMORBIDITÀ ED EVENTI AVVERSI ASSOCIATI IN PAZIENTI CON FIBRILLAZIONE ATRIALE: ANALISI DA UNO STUDIO DI COORTE EUROPEO SU OLTRE 11.000 PAZIENTI 107
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 107
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 106
The 12-lead ECG: A continuous reference for the cardiologist 106
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 105
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 104
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 104
Burden of disease and costs of infections associated with cardiac implantable electronic devices 102
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 99
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 99
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 98
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 97
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 96
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 95
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 94
Infective endocarditis in patients with cardiac implantable electronic devices: Impact of comorbidities on outcome 93
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 93
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 93
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 93
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 93
The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study 91
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 91
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome 90
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 90
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation 89
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 86
Clinical implications of assessing frailty in elderly patients treated with permanent cardiac pacing 84
Totale 13.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 37 227 95 74 70 67 71
2021/20221.164 72 80 20 38 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/20255.807 131 91 299 364 991 780 546 346 564 414 618 663
2025/20264.495 744 437 901 1.119 1.060 234 0 0 0 0 0 0
Totale 15.714